Drug Shortage Report for POTASSIUM PHOSPHATES INJECTION, USP
Report ID | 158777 |
Drug Identification Number | 02139545 |
Brand name | POTASSIUM PHOSPHATES INJECTION, USP |
Common or Proper name | Potassium Phosphates Injection, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM PHOSPHATE DIBASIC POTASSIUM PHOSPHATE MONOBASIC |
Strength(s) | 236MG 224MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 15 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-04-01 |
Estimated end date | 2022-11-23 |
Actual end date | 2022-11-01 |
Shortage status | Resolved |
Updated date | 2022-11-03 |
Company comments | On 100% allocation. Supply interruption effective September 1, 2022 until November 23, 2022 with coverage available using 50mL format. Please see communication for further details. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-04-13 | English | Compare |
v2 | 2022-04-13 | French | Compare |
v3 | 2022-06-08 | English | Compare |
v4 | 2022-06-08 | French | Compare |
v5 | 2022-07-07 | English | Compare |
v6 | 2022-07-07 | French | Compare |
v7 | 2022-07-07 | English | Compare |
v8 | 2022-07-07 | French | Compare |
v9 | 2022-08-04 | English | Compare |
v10 | 2022-08-04 | French | Compare |
v11 | 2022-08-21 | English | Compare |
v12 | 2022-08-21 | French | Compare |
v13 | 2022-11-03 | English | Compare |
v14 | 2022-11-03 | French | Compare |
Showing 1 to 14 of 14